SH1(3)_61888

August 6, 2025 BY

Clinical outlook: Oncologist Dr Sam Harris said he was confident the success of the trial will mean Cemiplimab will eventually be available via the Pharmaceutical Benefits Scheme. Photo: BENDIGO HEALTH